Headache is listed as a common side effect of Fostair?

Headache is listed as a common side effect of Fostair?

• A. Headache
• B. Nausea
• C. Dizziness
• D. Rash

Answer: (A)

Headache is a common adverse effect seen with inhaled combination therapies like Fostair, which contains a corticosteroid (beclomethasone) and a long-acting beta-agonist (formoterol). The combination can cause systemic effects, even though it’s inhaled, and headaches are one of the more frequently reported reactions in labeling. The “common” frequency means it occurs in a noticeable minority of patients, typically more than 1% but less than 10%. Understanding the context helps: inhaled corticosteroids and beta-agonists each have their own potential side effects, and headaches are a known, non-severe reaction that can arise from either component or their combined effect. Other options like nausea, dizziness, or rash can occur with medicines in general, but they are not typically listed as common adverse effects for this inhaler, even if they may appear in some individuals. If headaches persist or are troublesome, a clinician may review the therapy.

Headache is a common adverse effect seen with inhaled combination therapies like Fostair, which contains a corticosteroid (beclomethasone) and a long-acting beta-agonist (formoterol). The combination can cause systemic effects, even though it’s inhaled, and headaches are one of the more frequently reported reactions in labeling. The “common” frequency means it occurs in a noticeable minority of patients, typically more than 1% but less than 10%.

Understanding the context helps: inhaled corticosteroids and beta-agonists each have their own potential side effects, and headaches are a known, non-severe reaction that can arise from either component or their combined effect. Other options like nausea, dizziness, or rash can occur with medicines in general, but they are not typically listed as common adverse effects for this inhaler, even if they may appear in some individuals. If headaches persist or are troublesome, a clinician may review the therapy.